Direct Antiviral Treatments for Hepatitis C Virus Have Off-Target Effects of Oncologic Relevance in Hepatocellular Carcinoma

SIMPLE SUMMARY: Hepatitis C virus (HCV) eradication by direct-acting antiviral agents (DAAs) reduces de novo hepatocellular carcinoma incidence in cirrhosis; however, contrasting evidence on higher incidence of hepatocellular carcinoma (HCC) was reported in patients previously treated for HCC. Here,...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Cancers (Basel)
Главные авторы: Giovannini, Catia, Fornari, Francesca, Indio, Valentina, Trerè, Davide, Renzulli, Matteo, Vasuri, Francesco, Cescon, Matteo, Ravaioli, Matteo, Perrucci, Alessia, Astolfi, Annalisa, Piscaglia, Fabio, Gramantieri, Laura
Формат: Artigo
Язык:Inglês
Опубликовано: MDPI 2020
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7565876/
https://ncbi.nlm.nih.gov/pubmed/32961688
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12092674
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы